Showing 311-320 of 333 grants

Title Institution Researcher Program Duration Total Award Amount
Targeting the Autoimmune Germinal Center Axis in Type 1 Diabetes Vanderbilt University Medical Center (VUMC) Rachel Bonami Cures 01-September-2023 to 31-August-2025 $600,000.00
Targeting the Opposing Roles of Prostaglandin E2 Receptors, EP3 and EP4, in the Pathogenesis of Type One Diabetes Vanderbilt University Medical Center (VUMC) Maureen Gannon Cures 01-October-2023 to 30-September-2025 $200,000.00
Determination of Iatrogenic Hyperinsulinemia’s Contribution to Insulin Resistance and Endothelial Dysfunction in Type 1 Diabetes Vanderbilt University Medical Center (VUMC) Justin Gregory Improving Lives 01-March-2020 to 30-June-2025 $749,999.80
Bcl6 and the B/Tfh axis in type 1 diabetes pathogenesis Vanderbilt University Medical Center (VUMC) Dudley McNitt Cures 01-March-2024 to 28-February-2027 $265,320.00
Determination of autoreactive B lymphocyte development by ROS in T1D Vanderbilt University Medical Center (VUMC) Christopher Wilson Cures 01-July-2023 to 30-June-2026 $234,766.00
Developing Fit-For-Purpose Patient-reported Outcomes (PRO) Measure(s) in Type 1 Diabetes Vector Psychometric Group R. J. Wirth Cures 01-February-2025 to 31-March-2027 $797,087.00
Combining Arteriovenous Bundle and ECM-Based Biomaterial Technologies to Induce Potent Neovascularization Following Islet Transplantation Wake Forest University Health Sciences Giuseppe Orlando Cures 01-April-2025 to 31-March-2026 $248,692.00
Assess the antigenic profile in human T1D: from β-cell crinophagy to peripheral blood Washington University Xiaoxiao Wan Cures 01-April-2022 to 31-March-2027 $750,000.00
Enhancing Human Stem Cell-Derived Islet Survival and Function Using SA-PD-L1-Presenting Microgels Washington University Jeffrey Millman Cures 01-August-2024 to 31-July-2027 $1,125,000.00
Genetic Engineering to Improve Engraftment of Stem Cell-Derived Islets Washington University Jeffrey Millman Cures 01-February-2023 to 31-January-2026 $450,000.00